This is among the most important articles that we have published not just because it challenges the current tsunami of polypharmacy that is being thrust upon us,...
In our recent article “The Royal Commission Report is a Scientific and Ethical Failure", we reported on some of its key deficiencies. With the benefit of some...
In his column Biosafety Now, Dr. Simon Wain-Hobson revisits controversial gain of function research conducted in 2014 funded by US NIH contract HHSN26620070001 which successfully managed to transfer...
A large number of recent articles and studies raise crucial questions about the standards being applied to drug assessment and regulation.
This article is...
The team currently organising the Royal Commission of Inquiry into Covid-19 have misleadingly and mistakenly linked their publicity to a wholehearted endorsement of Covid...
An influential cross-party group of UK MPs has raised concerns that the Medicines and Healthcare Products Regulatory Agency (MHRA) knew of serious cardiac side...
Two papers published this week present starkly contrasting views of the scientific process. Dr. John Gibson economist at the University of Waikato, published “Cumulative...
